SCHEMBL138410

SCHEMBL138410

C#CCCC(=O)ON1C(=O)CCC1=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 2/20 0.31
PSMB5 P28074 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1700762 0.90 CYP1A2 (0.35) PSMB8PSMB5
SCHEMBL10061963 0.89
SCHEMBL1981540 0.88 CYP1A2 (0.42)
SCHEMBL26978299 0.87 MAPT (0.44)
SCHEMBL596794 0.87 MAPT (0.44)
SCHEMBL12092217 0.84 PSMB8 (0.30) PSMB8PSMB5
SCHEMBL10191090 0.83 PARL (0.32)
SCHEMBL43576 0.82 PSMB8 (0.35) PSMB8PSMB5
SCHEMBL31522720 0.81 PSMB8 (0.34) PSMB8PSMB5
SCHEMBL3489296 0.80 TSHR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10317393-B2 Alkynyl sugar analogs for labeling and visualization of glycoconjugates in cells ACADEMIA SINICA (TW) 2019-06-11 US claimed
US-20180106780-A1 ALKYNYL SUGAR ANALOGS FOR LABELING AND VISUALIZATION OF GLYCOCONJUGATES IN CELLS ACADEMIA SINICA (TW) 2018-04-19 US claimed
US-8906354-B2 Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes BRUKER BIOSPIN CORPORATION (US) 2014-12-09 US claimed
US-20120149887-A1 ALKYNYL SUGAR ANALOGS FOR LABELING AND VISUALIZATION OF GLYCOCONJUGATES IN CELLS ACADEMIA SINICA (TW) 2012-06-14 US claimed
US-20120058050-A1 LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES CONTAINING LIPOPHILIC LARGE STOKES SHIFT DYES BRUKER BIOSPIN CORPORATION 2012-03-08 US claimed
EP-2004713-A2 LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES Carestream Health, Inc. (US) 2008-12-24 EP claimed
US-20080268468-A1 Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells ACADEMIA SINICA (TW) 2008-10-30 US claimed
US-20080181965-A1 Loaded latex optical molecular imaging probes QUANTUM MEDICAL HOLDINGS, LLC 2008-07-31 US claimed
WO-2007120579-A2 LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES CARESTREAM HEALTH, INC. (US) 2007-10-25 WO claimed
CN-119868584-B Lysosome targeting chimeric body and preparation method and application thereof 郑州大学第一附属医院 2026-05-19 CN disclosed
CN-122011057-A Partially acylated non-natural sugar for metabolic markers and application 合肥领新博瑞生物科技有限公司 2026-05-12 CN disclosed
EP-4692115-A1 ANTIBODY-FUNCTIONAL SUBSTANCE CONJUGATE, ANTIBODY DERIVATIVE, AND COMPOUND, OR SALTS THEREOF AJINOMOTO CO., INC. (JP) 2026-02-11 EP disclosed
EP-3448417-B1 INSULIN DIMER-INCRETIN CONJUGATES MERCK SHARP & DOHME LLC (US) 2025-11-12 EP disclosed
US-20250302962-A1 BIOCONJUGATE COMPRISING A PHOTOSENSITIZER UNIT, METHOD FOR ITS PREPARATION AND USE THEREOF Universite de Bordeaux (FR) 2025-10-02 US disclosed
US-20080299595-A1 Tailored glycoproteomic methods for the sequencing, mapping and identification of cellular glycoproteins ACADEMIA SINICA (TW) 2008-12-04 US disclosed
US-20080268468-A1 Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells ACADEMIA SINICA (TW) 2008-10-30 US disclosed
US-20080206886-A1 Large stoke shift dye used for optical imaging TROPHY DENTAL INC. 2008-08-28 US disclosed
US-20080181965-A1 Loaded latex optical molecular imaging probes QUANTUM MEDICAL HOLDINGS, LLC 2008-07-31 US disclosed
US-20080113924-A1 Neuramindase Inhibitor NATIONAL INSTITUE OF ADVANCE INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-05-15 US disclosed
WO-2007120579-A2 LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES CARESTREAM HEALTH, INC. (US) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149887-A1 ALKYNYL SUGAR ANALOGS FOR LABELING AND VISUALIZATION OF GLYCOCONJUGATES IN CELLS FUCA2, ALG1, MANBA PSMB8 3109/4885PSMB5 3100/4885
US-20080181965-A1 Loaded latex optical molecular imaging probes MLX, LOXL1, EPX PSMB8 1705/4885PSMB5 607/4885
US-20250302962-A1 BIOCONJUGATE COMPRISING A PHOTOSENSITIZER UNIT, METHOD FOR ITS PREPARATION AND USE THEREOF XPA, XPNPEP1, XPNPEP2 PSMB8 1030/4885PSMB5 574/4885
US-20080268468-A1 Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells FUCA2, ALG1, FUCA1 PSMB8 3137/4885PSMB5 2948/4885
US-20080206886-A1 Large stoke shift dye used for optical imaging ESYT1, SLC7A5, ESYT2 PSMB8 4832/4885PSMB5 3597/4885
US-20080113924-A1 Neuramindase Inhibitor NMBR, NEU1, NMUR1 PSMB8 1800/4885PSMB5 1928/4885
US-20120058050-A1 LOADED LATEX OPTICAL MOLECULAR IMAGING PROBES CONTAINING LIPOPHILIC LARGE STOKES SHIFT DYES LASP1, LSS, SELL PSMB8 3443/4885PSMB5 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.